Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial)

NCT03674424 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Non-metastatic Muscle Invasive Bladder Cancer

Interventions

DRUG: Avelumab
PROCEDURE: cystectomy
COMBINATION_PRODUCT: CG
COMBINATION_PRODUCT: DD-MVAC
COMBINATION_PRODUCT: PG

Sponsor

Jules Bordet Institute

Collaborators

[object Object]